Filter results by content type

Search results for weight loss

Found 418 matches across the FoundMyFitness library.

418 results
142
Topic
Topic

Depression

Oct 7, 2026

“Clinicians diagnose depression as major depressive disorder based on a set of diagnostic criteria including one of two primary symptoms – depressed mood (e.g., sadness, irritability) and/or anhedonia (i.e., loss of interest or pleasure in doing things) – and four or more secondary symptoms – appetite or weight changes; sleep difficulties (e.g., insomnia or sleeping too much)…”

144
Science Digest

Semaglutide use reduces biological age by 3.1 years on average, with a 9% slower pace of aging as measured by DNA methylation.

Aug 1, 2026

“The biology of aging is increasingly seen as treatable, and drugs like semaglutide—once solely used for diabetes and weight loss—may be part of the solution. A recent study found that people with HIV who took semaglutide for 32 weeks experienced up to a 4.9-year reduction in biological age, as measured by changes in DNA methylation.”

145
Science Digest

Supplementing with propionate (a short chain fatty acid normally made from fiber in gut) prevents weight gain by increasing satiation.

May 10, 2016

“"The present results support a role specifically for colonic propionate in weight management and may provide a molecular explanation of recent data that have observed changes in the gut [range of bacteria] and associated [short chain fatty acid production] profiles in weight loss," researchers conclude.”

146
Science Digest

Late-life treatment with the GLP-1 receptor agonist semaglutide extended lifespan, preserved physical function, and improved memory in female mice.

Oct 2, 2026

“Calorie restriction does more than reduce body fat; it also changes how cells maintain and repair themselves. Researchers investigated whether semaglutide, a GLP-1 receptor agonist widely used for weight loss, could reproduce some of those effects when given late in life.”

148
Topic
Topic

NAD+

Jul 15, 2026

“Broad loss of sirtuin activity, potentially due to a reduction in NAD+, is typically observed with aging, and many animal models demonstrate that decreased SIRT1 activity may promote the pathogenesis of cardiovascular and neurological diseases.”

Results 141–150 of 418